Advancements In Ocular Therapies Will Transform Global Markets

Shared on01 May 25
Fair value Decreased 12%

Shared on24 Apr 25
Fair value Decreased 15%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25
Fair value Decreased 5.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.10%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 4.43%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 37%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.